US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 3.8800
  • +0.6200+19.02%
Close Nov 1 16:00 ET
  • 3.6200
  • -0.2600-6.70%
Post 20:02 ET
35.81MMarket Cap-629P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Single segment263.14K100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.24M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+1.08%